Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)
Status:
Completed
Trial end date:
2021-08-16
Target enrollment:
Participant gender:
Summary
The study will evaluate the safety and efficacy of orally-administered M5049 in Coronavirus
disease 2019 (COVID-19) pneumonia participants who are hospitalized but not on mechanical
ventilation.